Nifurtimox
To view the entire topic, please log in or purchase a subscription.
Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
- Not commercially available in the U.S.
- Available from the CDC under investigational protocols. Drug can be obtained by callingParasitic Diseases Public Inquiries (404-718-4745; e-mail chagas@cdc.gov). Outside of regular business hours call the CDC Emergency Operations Center (770-488-7100) and ask for the person on call for parasitic diseases.
NON-FDA APPROVED USES
- American trypanosomiasis (Chagas’ disease, T. cruzi): acute early phase of the disease.
- May be used in combination with eflornithine for the treatment of second-stage sleeping sickness.
-- To view the remaining sections of this topic, please log in or purchase a subscription --
INDICATIONS
FDA
- Not commercially available in the U.S.
- Available from the CDC under investigational protocols. Drug can be obtained by callingParasitic Diseases Public Inquiries (404-718-4745; e-mail chagas@cdc.gov). Outside of regular business hours call the CDC Emergency Operations Center (770-488-7100) and ask for the person on call for parasitic diseases.
NON-FDA APPROVED USES
- American trypanosomiasis (Chagas’ disease, T. cruzi): acute early phase of the disease.
- May be used in combination with eflornithine for the treatment of second-stage sleeping sickness.
There's more to see -- the rest of this entry is available only to subscribers.